Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 406-140-2 | CAS number: 114369-43-6 INDAR
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 26-April-1994 to 10-May-1994.
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 994
- Report date:
- 1994
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- Qualifier:
- according to guideline
- Guideline:
- other: Japan 59 NohSan Notification No. 4200
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.1100 (Acute Oral Toxicity)
- Version / remarks:
- 1998
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Test type:
- standard acute method
- Limit test:
- no
Test material
- Reference substance name:
- 4-(4-chlorophenyl)-2-phenyl-2-[(1H-1,2,4-triazol-1-yl)methyl]butanenitrile
- EC Number:
- 406-140-2
- EC Name:
- 4-(4-chlorophenyl)-2-phenyl-2-[(1H-1,2,4-triazol-1-yl)methyl]butanenitrile
- Cas Number:
- 114369-43-6
- Molecular formula:
- C19H17ClN4
- IUPAC Name:
- 4-(4-chlorophenyl)-2-phenyl-2-[(1H-1,2,4-triazol-1-yl)methyl]butanenitrile
- Test material form:
- solid
- Remarks:
- White solid.
Constituent 1
Test animals
- Species:
- rat
- Strain:
- other: Crl:CD.BR
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- Adult male and female Crl:CD rats were examined for physical abnormalities, identified by uniquely numbered ear tags, and quarantined for approximately one week. The animals were individually housed in suspended stainless steel cages (18x34x20 cm) with wire mesh fronts and bottoms. Cages were suspended above absorbent-paper pan liners which were changed 3 times a week. All animal rooms were environmentally controlled. The temperature and relative humidity were monitored 24 hr a day. During the study, the temperature ranged from 71°F to 73°F (22 to 23°C), and the relative humidity ranged from 39% to 49%. Although minor variations from these ranges occurred, they were of short duration and had no effect on the outcome of the study. The light cycle was automatically controlled, 12 hr on and 12 hr off. Throughout the test period, all rats had free access to filtered tap water (via automatic watering) and were fed PMI Purina Certified Rodent Diet.
On the day prior to treatment, male and female rats were selected from a healthy stock population, assigned to the study groups using a computer-generated sequence of random numbers, and fasted overnight. At the time they were dosed, the males were approximately 50 days old and the females were approximately 60 days old. The fasted body weights ranged from 187 to 237 g for males and from 185 to 210 g for females.
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- methylcellulose
- Details on oral exposure:
- The solid test substance was ground in a mortar with a pestle and mixed with 0.5% methylcellulose. The suspensions were created by weighing Fenbuconazole into a graduated tri-pour beaker and adding the appropriate amount of 0.5% methylcellulose. All dosing suspensions were mixed with a glass stir rod and kept stirring using a magnetic stir plate. It was necessary to use a Brinkman homogenizer for the 5000 mg/kg group, since at this concentration the suspensions would not pass through the gavage needle.
- Doses:
- 1000, 2000, 3000, 4000, and 5000 mg/kg bodyweight.
- No. of animals per sex per dose:
- 6 rats in each dose group.
- Details on study design:
- Observations and Determinations:
All animals were observed for signs of ill health, or reaction to treatment at 1, 2 and 4 hr after dosing and once daily thereafter for 14 days. Body weights were recorded on day 0 (prior to dosing) and on days 7 and 14. Body weights were determined for found-dead animals when they survived beyond the day of treatment.
Decedents were necropsied as death occurred. Surviving rats were killed on day 14 and necropsied. Necropsy consisted of a gross examination of organs in situ.
Dose was calculated on an "as is" basis; no adjustment was made for percent active ingredient. All animals were dosed at a constant volume of 10 ml/kg body weight, and were dosed within 1 hr of preparation of the suspensions. After dose administration, samples were collected and submitted for subsequent analytical verification of the target concentration. The results of analysis of the dosing suspensions showed a proximity to target concentration range of 90 to 125%.
Results and discussion
Effect levels
- Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 5 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- Dose-related mortality was observed. Mortality in the 5000 mg/kg bw dose group was 1 male rat, and 1 female each in the 4000 mg/kg and 5000 mg/kg dose groups.
- Clinical signs:
- other: Clinical signs were observed in all dose groups among females and in all but the 1000 mg/kg dose group among males. Clinical signs related to the test substance included (but were not limited to): white material in feces, scant, soft or no feces, ataxia,
- Gross pathology:
- Necropsy of the survivors revealed no gross changes. Necropsy of the
decedents revealed the following gross changes: yellow material/fluid In the stomach, reddening of the stomach mucosa, reddening and/or enlargement of the adrenals.
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- According to an acute oral toxicity study performed according to EPA guideline 870.110, Fenbuconazole was found to be of limited toxicity by a single oral administration (i.e., the acute oral LD50 exceeds 5000 mg/kg in male and female rats).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.